Latest filing published 24 May 2024 for Arch Biopartners Inc., €101k.
All filings by Daniel Abraham Muruve on record concern Arch Biopartners Inc. The record holds 2 filings, all for trades on 21 May 2024.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 24 May 2024, reports an option exercise of €101k in Arch Biopartners Inc. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations